Skip to main content
Top
Published in: European Journal of Medical Research 1/2021

Open Access 01-12-2021 | Case report

A case of solitary plasmacytoma of bone showing co-expression of both immunoglobulin light chains

Authors: Ryota Matsuoka, Noriaki Sakamoto, Takayasu Kato, Shigeru Chiba, Masayuki Noguchi

Published in: European Journal of Medical Research | Issue 1/2021

Login to get access

Abstract

Background

Solitary plasmacytoma of bone (SPB) is a rare plasma cell neoplasm. It arises in bone as a single locus in the absence of any plasma cell myeloma lesions. Plasma cell neoplasms intrinsically express only one immunoglobulin light chain (IgL)—kappa or lambda—and using this fact, kappa/lambda deviation is the decisive factor for diagnosis. Co-expression of both IgLs in a single tumor cell is extremely rare.

Case presentation

We report a case of SPB that arose in the vertebra of a 52-year-old Japanese woman. Histologically, the resected mass showed diffuse plasma cell proliferation. Dual IgL expression was detected by flow cytometry, immunohistochemistry, and in situ hybridization (ISH) targeting IgL mRNA.

Conclusion

We have presented an extremely rare case of SPB showing dual expression of kappa and lambda IgLs. This unusual case of plasma cell neoplasia might represent a possible exceptional example of failure of “IgL isotypic exclusion.”
Appendix
Available only for authorised users
Literature
1.
go back to reference Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood. 2000;96:2037–44.CrossRef Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood. 2000;96:2037–44.CrossRef
2.
go back to reference Kumar P, et al. Solitary plasmacytoma of the proximal tibia in an adolescent. Pediatr Blood Cancer. 2011;56:158–60.CrossRef Kumar P, et al. Solitary plasmacytoma of the proximal tibia in an adolescent. Pediatr Blood Cancer. 2011;56:158–60.CrossRef
3.
go back to reference Kyle RA, Vincent Rajkumar S. Monoclonal gammopathy of undetermined significance. Br J Haematol. 2006;134:573–89.CrossRef Kyle RA, Vincent Rajkumar S. Monoclonal gammopathy of undetermined significance. Br J Haematol. 2006;134:573–89.CrossRef
4.
go back to reference de Waal EGM, et al. Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands. Br J Haematol. 2016;175:661–7.CrossRef de Waal EGM, et al. Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands. Br J Haematol. 2016;175:661–7.CrossRef
5.
go back to reference Hill QA, Rawstron AC, De Tute RM, Owen RG. Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis. Blood. 2014;124:1296–9.CrossRef Hill QA, Rawstron AC, De Tute RM, Owen RG. Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis. Blood. 2014;124:1296–9.CrossRef
6.
go back to reference Knobel D, et al. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer. 2006;6:1–9.CrossRef Knobel D, et al. Prognostic factors in solitary plasmacytoma of the bone: a multicenter Rare Cancer Network study. BMC Cancer. 2006;6:1–9.CrossRef
8.
go back to reference Dunn TM, Wormsley S, Taub FE, Pontzer CH. Increased T cell cytotoxicity by Betathine(TM)-induced upregulation of TNFα. Int J Immunopharmacol. 2000;22:213–27.CrossRef Dunn TM, Wormsley S, Taub FE, Pontzer CH. Increased T cell cytotoxicity by Betathine(TM)-induced upregulation of TNFα. Int J Immunopharmacol. 2000;22:213–27.CrossRef
9.
go back to reference Jurišić V, Čolović M. Correlation of sera TNF-α with percentage of bone marrow plasma cells, LDH, β2-microglobulin, and clinical stage in multiple myeloma. Med Oncol. 2002;19:133–9.CrossRef Jurišić V, Čolović M. Correlation of sera TNF-α with percentage of bone marrow plasma cells, LDH, β2-microglobulin, and clinical stage in multiple myeloma. Med Oncol. 2002;19:133–9.CrossRef
10.
go back to reference Jurisic V, Colovic N, Konjevic G, Minic I, Colovic M. An aggressive extramedullary cutaneous plasmacytoma associated with extreme alterations in the innate immune system. Onkologie. 2010;33:113–5.CrossRef Jurisic V, Colovic N, Konjevic G, Minic I, Colovic M. An aggressive extramedullary cutaneous plasmacytoma associated with extreme alterations in the innate immune system. Onkologie. 2010;33:113–5.CrossRef
11.
go back to reference Kroft SH. Monoclones, monotypes, and neoplasia: pitfalls in lymphoma diagnosis. Am J Clin Pathol. 2004;121:457–9.CrossRef Kroft SH. Monoclones, monotypes, and neoplasia: pitfalls in lymphoma diagnosis. Am J Clin Pathol. 2004;121:457–9.CrossRef
12.
go back to reference Hristov AC, Comfere NI, Vidal CI, Sundram U. Kappa and lambda immunohistochemistry and in situ hybridization in the evaluation of atypical cutaneous lymphoid infiltrates. J Cutan Pathol. 2020;47:1103–10.CrossRef Hristov AC, Comfere NI, Vidal CI, Sundram U. Kappa and lambda immunohistochemistry and in situ hybridization in the evaluation of atypical cutaneous lymphoid infiltrates. J Cutan Pathol. 2020;47:1103–10.CrossRef
13.
go back to reference Moore MW, Durdik J, Persiani DM, Selsing E. Deletions of κ chain constant region genes in mouse λ chain-producing B cells involve intrachromosomal DNA recombinations similar to V-J joining. Proc Natl Acad Sci USA. 1985;82:6211–5.CrossRef Moore MW, Durdik J, Persiani DM, Selsing E. Deletions of κ chain constant region genes in mouse λ chain-producing B cells involve intrachromosomal DNA recombinations similar to V-J joining. Proc Natl Acad Sci USA. 1985;82:6211–5.CrossRef
14.
go back to reference Retter MW, Nemazee D. Receptor editing occurs frequently during normal B cell development. J Exp Med. 1998;188:1231–8.CrossRef Retter MW, Nemazee D. Receptor editing occurs frequently during normal B cell development. J Exp Med. 1998;188:1231–8.CrossRef
15.
go back to reference Xu D. Dual surface immunoglobulin light-chain expression in B-cell lymphoproliferative disorders. Arch Pathol Lab Med. 2006;130:853–6.CrossRef Xu D. Dual surface immunoglobulin light-chain expression in B-cell lymphoproliferative disorders. Arch Pathol Lab Med. 2006;130:853–6.CrossRef
16.
go back to reference Siminovitch KA, Moore MW, Durdik J, Selsing E. The human kappa deleting element and the mouse recombining segment share DNA sequence homology. Nucleic Acids Res. 1987;15:2699–705.CrossRef Siminovitch KA, Moore MW, Durdik J, Selsing E. The human kappa deleting element and the mouse recombining segment share DNA sequence homology. Nucleic Acids Res. 1987;15:2699–705.CrossRef
17.
go back to reference Vettermann C, Schlissel MS. Allelic exclusion of immunoglobulin genes: models and mechanisms. Immunol Rev. 2010;237:22–42.CrossRef Vettermann C, Schlissel MS. Allelic exclusion of immunoglobulin genes: models and mechanisms. Immunol Rev. 2010;237:22–42.CrossRef
18.
go back to reference Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol. 2006;6:728–40.CrossRef Nemazee D. Receptor editing in lymphocyte development and central tolerance. Nat Rev Immunol. 2006;6:728–40.CrossRef
19.
go back to reference Vela JL, Aït-Azzouzene D, Duong BH, Ota T, Nemazee D. Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production. Immunity. 2008;28:161–70.CrossRef Vela JL, Aït-Azzouzene D, Duong BH, Ota T, Nemazee D. Rearrangement of mouse immunoglobulin kappa deleting element recombining sequence promotes immune tolerance and lambda B cell production. Immunity. 2008;28:161–70.CrossRef
20.
go back to reference Diaw L, Siwarski D, DuBois W, Jones G, Huppi K. Double producers of kappa and lambda define a subset of B cells in mouse plasmacytomas. Mol Immunol. 2000;37:775–81.CrossRef Diaw L, Siwarski D, DuBois W, Jones G, Huppi K. Double producers of kappa and lambda define a subset of B cells in mouse plasmacytomas. Mol Immunol. 2000;37:775–81.CrossRef
21.
go back to reference Jiang AS, et al. Plasma cell myeloma with dual expression of kappa and lambda light chains. Int J Clin Exp Pathol. 2018;11:4718–23.PubMedPubMedCentral Jiang AS, et al. Plasma cell myeloma with dual expression of kappa and lambda light chains. Int J Clin Exp Pathol. 2018;11:4718–23.PubMedPubMedCentral
22.
go back to reference Gentry M, Pettenati M, Pang CS. Biclonal light chain gammopathy with aberrant CD33 expression in secondary plasma cell leukemia. Int J Clin Exp Pathol. 2013;6:2224–9.PubMedPubMedCentral Gentry M, Pettenati M, Pang CS. Biclonal light chain gammopathy with aberrant CD33 expression in secondary plasma cell leukemia. Int J Clin Exp Pathol. 2013;6:2224–9.PubMedPubMedCentral
23.
go back to reference Jiwani S, Bornhost J, Alapat D. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains. Int J Clin Exp Pathol. 2015;8:8536–44.PubMedPubMedCentral Jiwani S, Bornhost J, Alapat D. Biphenotypic plasma cell myeloma: two cases of plasma cell neoplasm with a coexpression of kappa and lambda light chains. Int J Clin Exp Pathol. 2015;8:8536–44.PubMedPubMedCentral
24.
go back to reference Shi Z, et al. More than one antibody of individual B cells revealed by single-cell immune profiling. Cell Discov. 2019;5:1–13.CrossRef Shi Z, et al. More than one antibody of individual B cells revealed by single-cell immune profiling. Cell Discov. 2019;5:1–13.CrossRef
Metadata
Title
A case of solitary plasmacytoma of bone showing co-expression of both immunoglobulin light chains
Authors
Ryota Matsuoka
Noriaki Sakamoto
Takayasu Kato
Shigeru Chiba
Masayuki Noguchi
Publication date
01-12-2021
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2021
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-021-00621-8

Other articles of this Issue 1/2021

European Journal of Medical Research 1/2021 Go to the issue